Clostridium Difficile Infections Treatment Market - Key Growth Factors and Forecast 2017 - 2025

Bacterial infection caused by Clostridium Difficile (C. difficile) species is referred as Clostridium difficile infection. People treated with antibiotics are at high risk of Clostridium difficile infection. Antibiotics interfere with normal functioning of gut flora present in the human body and enables C. difficile bacterium to infect the body. People admitted in the hospital are also at high risk of acquiring C. difficile infection owing to the presence of medical condition, surgical, non surgical wounds and inclusion of antibiotics in treatment therapy. According to the Centers for Disease Control and Prevention (CDC), the U.S., C. difficile infection leads to around 14,000 deaths each year in the U.S. alone.

Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/15775

Common symptoms of C. difficile infection include fever, watery diarrhea, nausea, loss of appetite, abdominal pain, dehydration, and weight loss. Diagnosis of C. difficile infection is done with blood tests and colon (bowel) examination. Colon examination can be direct or indirect. In addition, cytotoxicity assay, toxin enzyme linked immune assay (ELISA), real time polymerase chain reaction (PCR) and stool examinations are also performed.

Rising geriatric population is one of the driving factor for C. difficile infection treatment market owing to weaker immune system. Furthermore, increasing hospital admissions and rising awareness about C. difficile infection are some other drivers that are fueling the growth of the global C. difficile infection treatment market. While on the other hand, rising drug resistance of the C. difficile bacteria is posing a challenge for the growth of the global C. difficile infection treatment market.

Geographically, the global C. difficile infection treatment market is segmented into North America, Europe, Asia Pacific and Rest of the World (RoW). Presently, North America is dominating the global C. difficile infection treatment market. Europe is the second largest market in the global C. difficile infection treatment market. High rate of hospital admission, presence of large pool of geriatric population and availability of advanced healthcare facilities are some of the factors that are driving the C. difficile infection treatment market in North America and Europe. Asia Pacific is anticipated to be the fastest growing market in the near future. Factors such as rapidly developing healthcare infrastructure, government support to boost healthcare development in respective country on the grounds of rapidly developing medical tourism industry in this region are some of the major drivers that are driving the C. difficile infection treatment market in Asia Pacific.

Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/15775

India and China together account for the largest population pool in the world. Thus, India and China are expected to account for largest pool of geriatric population in the near future. Availability of largest pool of geriatric population is anticipated to fuel the growth of the C. difficile infection treatment market in these countries. Brazil, Argentina and Mexico are the countries in the Rest of the World (RoW) that are expected to show faster growth rate than African countries owing to availability of well developed healthcare infrastructure and regulatory framework. African countries are anticipated to show slower growth rate in near future owing to poor economy and lack of healthcare facilities.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.